scholarly journals Use of a negative selectable marker for rapid selection of recombinant vaccinia virus

BioTechniques ◽  
2011 ◽  
Vol 50 (5) ◽  
pp. 303-309 ◽  
Author(s):  
Stacy D. White ◽  
Kip Conwell ◽  
Jeffrey O. Langland ◽  
Bertram L. Jacobs
Keyword(s):  
Vaccinia Virus ◽  
Selectable Marker ◽  
Recombinant Vaccinia Virus ◽  
Recombinant Vaccinia ◽  
Negative Selectable Marker ◽  
Selection Of

Anti-tumoral Effect of Recombinant Vaccinia Virus through US Guided Injection in a Rabbit Model of Hepatic VX2 Carcinoma

2006 ◽  
Vol 54 (2) ◽  
pp. 103 ◽  
Author(s):  
Jong Young Oh ◽  
Byeong Ho Park ◽  
Myong Jin Kang ◽  
Jin Han Cho ◽  
Jong Cheol Choi ◽  
...  
Keyword(s):  
Vaccinia Virus ◽  
Rabbit Model ◽  
Recombinant Vaccinia Virus ◽  
Recombinant Vaccinia ◽  
Vx2 Carcinoma

Characterization of a recombinant vaccinia virus expressing human melanoma-associated antigen p97.

1988 ◽  
Vol 62 (1) ◽  
pp. 176-180 ◽  
Author(s):  
S L Hu ◽  
G D Plowman ◽  
P Sridhar ◽  
U S Stevenson ◽  
J P Brown ◽  
...  
Keyword(s):  
Vaccinia Virus ◽  
Recombinant Vaccinia Virus ◽  
Human Melanoma ◽  
Recombinant Vaccinia

Human cytomegalovirus UL97 kinase confers ganciclovir susceptibility to recombinant vaccinia virus.

1994 ◽  
Vol 68 (12) ◽  
pp. 8423-8427 ◽  
Author(s):  
C Metzger ◽  
D Michel ◽  
K Schneider ◽  
A Lüske ◽  
H J Schlicht ◽  
...  
Keyword(s):  
Vaccinia Virus ◽  
Human Cytomegalovirus ◽  
Recombinant Vaccinia Virus ◽  
Recombinant Vaccinia

Protection of vaccinia‐primed macaques against SIV mne infection by combination immunization with recombinant vaccinia virus and SIV mne gp160

1993 ◽  
Vol 22 (2-3) ◽  
pp. 92-99
Author(s):  
Shiu‐Lok Hu ◽  
Virginia Stallard ◽  
Kraig Abrams ◽  
Glen N. Barber ◽  
LaRene Kuller ◽  
...  
Keyword(s):  
Vaccinia Virus ◽  
Recombinant Vaccinia Virus ◽  
Recombinant Vaccinia

scholarly journals Shifting immunodominance pattern of two cytotoxic T-lymphocyte epitopes in the F glycoprotein of the Long strain of respiratory syncytial virus

2004 ◽  
Vol 85 (11) ◽  
pp. 3229-3238 ◽  
Author(s):  
Carolina Johnstone ◽  
Patricia de León ◽  
Francisco Medina ◽  
José A. Melero ◽  
Blanca García-Barreno ◽  
...  
Keyword(s):  
Respiratory Syncytial Virus ◽  
Vaccinia Virus ◽  
T Lymphocyte ◽  
Cytotoxic T Lymphocyte ◽  
Recombinant Vaccinia Virus ◽  
Recombinant Vaccinia ◽  
F Protein ◽  
Syncytial Virus ◽  
Lymphocyte Responses

Human respiratory syncytial virus (RSV) is a major cause of respiratory infection in children and in the elderly. The RSV fusion (F) glycoprotein has long been recognized as a vaccine candidate as it elicits cytotoxic T-lymphocyte (CTL) and antibody responses. Two murine H-2Kd-restricted CTL epitopes (F85–93 and F92–106) are known in the F protein of the A2 strain of RSV. F-specific CTL lines using BCH4 fibroblasts that are persistently infected with the Long strain of human RSV as stimulators were generated, and it was found that in this strain only the F85–93 epitope is conserved. Motif based epitope prediction programs and an F2 chain deleted F protein encoded in a recombinant vaccinia virus enabled identification of a new epitope in the Long strain, F249–258, which is presented by Kd as a 9-mer (TYMLTNSEL) or a 10-mer (TYMLTNSELL) peptide. The results suggest that the 10-mer might be a naturally processed endogenous Kd ligand. The CD8+ T-lymphocyte responses to epitopes F85–93 and F249–258 present in the F protein of RSV Long were found to be strongly skewed to F85–93 in in vitro multispecific CTL lines and in vivo during a secondary response to a recombinant vaccinia virus that expresses the entire F protein. However, no hierarchy in CD8+ T-lymphocyte responses to F85–93 and F249–258 epitopes was observed in vivo during a primary response.

Serum antibodies to HIV-1 in recombinant vaccinia virus recipients boosted with purified recombinant gp160

1992 ◽  
Vol 12 (6) ◽  
pp. 429-439 ◽  
Author(s):  
David C. Montefiori ◽  
◽  
Barney S. Graham ◽  
Srisakul Kliks ◽  
Peter F. Wright
Keyword(s):  
Vaccinia Virus ◽  
Recombinant Vaccinia Virus ◽  
Serum Antibodies ◽  
Recombinant Vaccinia ◽  
Hiv 1
Sign in / Sign up

Export Citation Format

Share Document